Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › Goserelin

Goserelin

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of Goserelin

35 trials tracked of Goserelin: 11 in phase 3 or 4 and 1 with published results. The most-cited published study has 35 citations.

35Trials tracked
11Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 3 11 Phase 2 21 Phase 1 1 Other / NA 2
  1. Phase 3 Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC Completed · 35 cited
  2. Phase 3 Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer Completed
  3. Phase 3 A Trial of Degarelix in Patients With Prostate Cancer Completed
  4. Phase 3 SWOG-9346, Hormone Therapy in Treating Men With Stage IV Prostate Cancer Completed
  5. Phase 3 Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer Completed
  6. Phase 3 Study for Women and Men With Hormone-receptor Positive Locally Advanced or Metastatic Breast Cancer Completed
Show 29 more trials
  1. Phase 3 Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer Completed
  2. Phase 3 S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer Completed
  3. Phase 3 Investigation of the Effect of Degarelix in Terms of Prostate Volume Reduction in Prostate Cancer Patients Completed
  4. Phase 3 S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer Completed
  5. Phase 3 Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer Completed
  6. Phase 2 Tecemotide (L-BLP25) in Prostate Cancer Completed
  7. Phase 2 A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer Completed
  8. Phase 2 Selective Neoadjuvant Treatment According to Immunohistochemical Subtype for HER2 Negative Breast Cancer Patients Completed
  9. Phase 2 Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases Completed
  10. Phase 2 Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant or Letrozole, Based on Prior Endocrine Therapy, in Patients With PIK3CA Mutant, HR+, HER2- Advanced Breast Cancer Who Have Progressed on or After Prior Treatments Completed
  11. Phase 2 Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer Completed
  12. Phase 2 S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer Completed
  13. Phase 2 LHRH Analogue Therapy With Enzalutamide or Bicalutamide in Treating Patients With Hormone Sensitive Prostate Cancer Completed
  14. Phase 2 Abiraterone Prednisone and Hormonal Therapy Before and During Radiation Therapy in Localized Prostate Cancer Completed
  15. Phase 2 Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer Completed
  16. Phase 2 Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women Completed
  17. Phase 2 Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer Completed
  18. Phase 2 Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer Completed
  19. Phase 2 Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer Completed
  20. Phase 2 Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer Completed
  21. Phase 2 Bipolar Androgen-based Therapy for Prostate Cancer (BAT) Completed
  22. Phase 2 Alternative Dosing Schedule of Palbociclib in Metastatic Hormone Receptor Positive Breast Cancer Completed
  23. Phase 2 Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer Completed
  24. Phase 2 Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer Completed
  25. Phase 2 Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer Completed
  26. Phase 2 Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women Completed
  27. Phase 1 TEEL Study- Phase 1 Tamoxifen and Ribociclib (LEE011) in Advanced ER+ (HER2 Negative) Breast Cancer Completed
  28. N/A Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland Completed
  29. N/A Dose-Response of Gonadal Steroids and Bone Turnover in Older Men Completed

Showing the 35 most-cited and recently-updated of 35 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.